Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
- 1 May 1993
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 341 (8853), 1113-1116
- https://doi.org/10.1016/0140-6736(93)93127-m
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP‐met30)Clinical Genetics, 1991
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Journal of Clinical Investigation, 1990
- Reversal by Liver Transplantation of the Complications of Primary Hyperoxaluria as Well as the Metabolic DefectNew England Journal of Medicine, 1989
- Liver TransplantationNew England Journal of Medicine, 1989
- Homozygosity for the transthyretin‐met30‐gene in two Swedish sibs with familial amyloidotic polyneuropathyClinical Genetics, 1988
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).Journal of Clinical Investigation, 1986
- Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1984
- Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)Biochemical and Biophysical Research Communications, 1983
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980